Clinical trial
Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With…
NCT00182169 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00182169 |
|---|---|
| Title | Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure |
| Official title | Randomized, Placebo Control, Clinical Trial Evaluating the Effect of Human Recombinant Growth Hormone in Patients With Severe Congestive Heart Failure. The Growth Hormone In Heart Failure Trial (GIFT) |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Human recombinant growth hormone |
| Enrollment | 80 |
| Start date | Jul 1, 1997 |
| Completion | Jun 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: